Substituted porphyrins

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07807825

ABSTRACT:
To improve bioavailability of the catalytic metalloporphyrin-based SOD mimics Mn(III) 5,10,15,20-tetrakis[N-ethylpyridinium-2-yl]porphyrin (MnTE-2-PyP5+) and Mn(III) 5,10,15,20-tetrakis[N,N′-diethylimidazolium-2-yl]porphyrin (MnTDE-2-ImP5+), three new Mn(III) porphyrins, bearing oxygen atoms within side chains, were synthesized and characterized: Mn(III) 5,10,15,20-tetrakis[N-(2-methoxyethyl)pyridinium-2-yl]porphyrin (MnTMOE-2-PyP5+), Mn(III) 5,10,15,20-tetrakis[N-methyl-N′-(2-methoxyethyl)imidazolium-2-yl]porphyrin (MnTM,MOE-2-ImP5+) and Mn(III) 5,10,15,20-tetrakis[N,N′-di(2-methoxyethyl)imidazolium-2-yl]porphyrin (MnTDMOE-2-ImP5+). The catalytic rate constants for O2dismutation (and the related metal-centered redox potentials vs NHE) for the new compounds are: log kcat=8.04 (E1/2=+251 mV) for MnTMOE-2-PyP5+, log k.cat=7.98 (E1/2=+356 mV) for MnTM,MOE-2-ImP5+and log kcat=7.59 (E1/2=+365 mV) for MnTDMOE-2-ImP5+. At 30 μM levels none of the new compounds were toxic, and allowed SOD-deficientE. colito grow nearly as well as wild type. At 3 μM levels, the MnTDMOE-2-ImP5+, bearing an oxygen atom within each of the eight side chains, was the most effective and offered much higher protection than MnTE-2-PyP5+, while MnTDE-2-ImP5+was inefficient. These new porphyrins were compared to Mn(III) N-alkylpyridylporphyrins. While longer-chain n-alkyl members of the series exerted toxicity at higher concentration levels, they were very effective at submicromolar levels. Thus, 0.3 μM Mn(III) tetrakis(N-n-hexyl-pyridinum-2-yl)porphyrin and its n-octyl analogue offered the same level of protection as did >10 μM methyl and ethyl porphyrins. The kcatof methyl and n-octyl porphyrins are identical, but n-octyl is −10-fold more lipophilic. Therefore, the 30-fold improvement in bioavailability appears to be due to the increase in lipophilicity. MnTDMOE-2-ImP5+and longer-chain Mn(III) N-alkylpyridylporphyrins may offer better treatment for oxidative stress injuries than the previously studied MnTE-2-PyP5+and MnTDE-2-ImP5+.

REFERENCES:
patent: 6479477 (2002-11-01), Crapo et al.
patent: 6544975 (2003-04-01), Crapo et al.
patent: 1450066 (2003-10-01), None
patent: 02 242860 (1990-09-01), None
patent: WO0075144 (2000-12-01), None
Pinedo et al., “Translational Research . . . ”, The Oncologist 2000; 5(suppl 1); 1-2. [www.TheOncologist.com].
McMahon, G., “VEGF Receptor Signaling in Tumor Angeiogenisis.”, The Oncologist 2000; 5(suppl 1); 3-10. [www.TheOncologist.com].
Hunt et al., “Amphiphilic peroxynitrite . . . ”, Chemistry & Biology 1997, vol. 4 No. 11, pp. 845-858.
Dancil et al., “Synthesis and Aggregation of Cationic Porphyrins”J. Heterocyclic Chem., 34, 749-755 (1997).
Gong et al., “Preparation and Characterization of Porphyrin Nanoparticles”J. Am. Chem. Soc. 124, 14290-14291 (2002).
Hunt et al, “Amphiphilic Peroxynitrite Decomposition Catalysts in Liposomal Assemblies”Chemistry and Biology. 4:845-858 (Nov. 1997).
International Search Report and Written Opinion for International Application No. PCT/US2005/02691, May 10, 2005.
Woehrle D et al. Metal chelates of porphyrin derivatives as sensitizers in photooxidation of sulphur compounds and in photodynamic therapy of cancer. Izvestia Akademii Nauk SSR. Seria Himiceskaa, Moscow, Russia. Jan. 1, 1994; 12: 2071-2082.
Gong X et al. Preparation and characterization of porphyrin nanoparticles. J Am Chem Soc. 2002; 124: 14290-14291.
Gong X. Large substituent containing porphyrin derivative, its preparation and application as small molecular antioxidant. Chemical Abstracts Service, Columbus, Ohio. Oct. 22, 2003: 3 pp.
Supplementary European Search Report, EP 05712218.6, mailed May 19, 2010.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted porphyrins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted porphyrins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted porphyrins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4232795

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.